Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery ...

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

A University of Pacific professor and his team developed a drug delivery system that they say could offer a game-changing ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global ...

The FDA approves Journavx, the first new non-opioid pain medication in over 20 years, offering a safer alternative for ...

The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...